CYTOR has been reported as an adverse factor of pan cancers via promoting proliferation, migration, invasion, metastasis, and drug resistance of tumor cells (Wang et al., 2018; Zhang and Li, 2018; Liu et al., 2019a; Zou et al., 2019; Chen W. et al., 2020; Zhu et al., 2020a). The gene discussed is CYTOR; the disease is neoplasm.